Pediatrix Medical Group (NYSE:MD) Releases Earnings Results, Beats Estimates By $0.07 EPS

Pediatrix Medical Group (NYSE:MD) posted its earnings results on Friday. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07, Briefing.com reports. Pediatrix Medical Group had a positive return on equity of 10.59% and a negative net margin of 12.58%. The company had revenue of $511.20 million for the quarter, compared to analyst estimates of $498.87 million. During the same quarter last year, the company earned $0.29 earnings per share. The company’s revenue for the quarter was up .9% on a year-over-year basis.

Pediatrix Medical Group Stock Performance

NYSE:MD opened at $15.21 on Friday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.38 and a quick ratio of 1.38. The business has a fifty day simple moving average of $11.62 and a two-hundred day simple moving average of $9.40. Pediatrix Medical Group has a 1 year low of $6.62 and a 1 year high of $15.42. The company has a market capitalization of $1.31 billion, a P/E ratio of -5.02, a P/E/G ratio of 1.91 and a beta of 1.55.

Insiders Place Their Bets

In other news, CEO James D. Swift sold 11,100 shares of Pediatrix Medical Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $10.79, for a total value of $119,769.00. Following the completion of the transaction, the chief executive officer now directly owns 170,001 shares in the company, valued at approximately $1,834,310.79. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Laura A. Linynsky sold 7,000 shares of Pediatrix Medical Group stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $11.16, for a total transaction of $78,120.00. Following the completion of the sale, the director now owns 30,805 shares of the company’s stock, valued at approximately $343,783.80. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO James D. Swift sold 11,100 shares of Pediatrix Medical Group stock in a transaction on Friday, August 30th. The shares were sold at an average price of $10.79, for a total value of $119,769.00. Following the sale, the chief executive officer now directly owns 170,001 shares of the company’s stock, valued at $1,834,310.79. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 68,100 shares of company stock valued at $701,889 over the last ninety days. 2.00% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of brokerages recently commented on MD. Truist Financial increased their price target on Pediatrix Medical Group from $10.00 to $13.00 and gave the company a “hold” rating in a research report on Monday, October 7th. StockNews.com raised Pediatrix Medical Group from a “sell” rating to a “hold” rating in a research report on Wednesday, August 7th. Jefferies Financial Group raised Pediatrix Medical Group from a “hold” rating to a “buy” rating and increased their price target for the company from $8.00 to $14.00 in a research report on Thursday, September 26th. Finally, UBS Group increased their price target on Pediatrix Medical Group from $9.00 to $10.50 and gave the company a “neutral” rating in a research report on Friday, August 9th. Five equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $10.90.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.